Cellular Pathology Referrals - Christie Pathology Partnership
A Contract Award Notice
by GATESHEAD HEALTH NHS FOUNDATION TRUST
- Source
- Find a Tender
- Type
- Contract (Services)
- Duration
- not specified
- Value
- £3K
- Sector
- HEALTH
- Published
- 21 Jul 2025
- Delivery
- not specified
- Deadline
- n/a
Concepts
Location
United Kingdom:
1 buyer
- Gateshead Health NHS Trust Gateshead
1 supplier
- Christie Pathology Partnership Manchester
Description
Cellular Pathology Referral Tests
Total Quantity or Scope
Description of Services; The contract is for the provision of cellular pathology tests. Contract Award Statement: The intention is to award the contract to The Christie Pathology Partnership LLP following the direct award process C under the Provider Selection Regime. Contract Value: The approximate lifetime value of the contract is £3000. Contract Period: The services are intended to be provided from 2025 to 2028
Award Detail
| 1 | Christie Pathology Partnership (Manchester)
|
Award Criteria
| the existing provider is satisfying the original contract and will likely satisfy the proposed contract to a sufficient standard | 100 |
CPV Codes
- 85145000 - Services provided by medical laboratories
Legal Justification
This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Procurement Act 2023 do not apply to this award. The standstill period begins on the day after the publication of this notice. Representations by providers must be made to the relevant authority by 30th July 2025. This contract has not yet formally been awarded; this notice serves as an intention to award under the PSR.
Other Information
** PREVIEW NOTICE, please check Find a Tender for full details. ** This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Procurement Act 2023 do not apply to this award. The standstill period begins on the day after the publication of this notice. Representations by providers must be made to the relevant authority by 30th July 2025. Address for Written Representations: ghnt.psr@nhs.net This contract has not yet formally been awarded; this notice serves as an intention to award under the PSR. Details of the Award Decision-Makers: Dr Kate MacDougall. Conflicts of Interest: There were no conflicts of interest identified among the decision makers. Rationale: The Authority intends to directly award a contract to The Christie Pathology Partnership under the Direct Award Process C. This decision to proceed with Direct Award C is based on the following criteria: Second Opinion are requested from experts in a chosen speciality that are employed in a UKAS accredited laboratory and participate in EQA for that speciality. Turnaround times for results are also a consideration for utilising the referral service with this provider. Test referrals are made to UKAS accredited laboratories with acceptable clinical interpretation, availability of clinical advice and turnarounds that facilitate compliance with RCPath guidelines. Referrals are often made in accordance with established regional referral pathways in line with MDT arrangements for tertiary specialities. Genomic test referrals are made in accordance with genomic hub guidelines.
Reference
- ocds-h6vhtk-0562e8
- FTS 041630-2025